ALK-Abelló (Germany)

ALK-Abelló (Germany)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Germany), Germany, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

61%


Total
Publications

83


Total Open
Publications

51


Total
Citations

1K


Open Access
Percentage

61%


Total
Publications

83


Total Open
Publications

51


Total
Citations

1K

Wikipedia

Website

download

Breakdown

31% 16% 14% 39%

Publisher Open

31%

Both

16%

Other Platform Open

14%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

9

Hybrid 23%

9

No Guarantees 54%

21

Other Platform Open

Domain 44%

11

Institution 28%

7

Other Internet 24%

6

Preprint 16%

4

Public 4%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
11
Europe PMC
Domain
9
DOI
Other Internet
6
Unknown Repository
Other Internet
4
King's College London - Research Portal
Institution
2
bioRxiv
Preprint
2
Universitätsbibliothek der Freien Universität Berlin - Refubium
Institution
1
Universidad del Pais Vasco - Communities in ADDI
Institution
1
Universidad de Las Palmas de Gran Canaria - Acceda
Institution
1
Semantic Scholar
Public
1
1 / 2

Data updated 17 June 2024

Share

Share

Share